Recent Quarter Total Invested
$232.94 M
Recent Quarter Institutional Ownership Percentage
51.35%
Total Invested of Last Quarter
$110.48 M
Ownership Percentage of Last Quarter
57.67%
Aquestive Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BRATTON CAPITAL MANAGEMENT, L.P. | 11/12/2024 | 9.81 M | $48.86 M | 0.00% | 10.77% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 5.82 M | $29.00 M | 100.00% | 6.39% |
| VR ADVISER, LLC | 11/14/2024 | 5.56 M | $27.67 M | 0.00% | 6.10% |
| VANGUARD GROUP INC | 11/13/2024 | 4.26 M | $21.23 M | 0.85% | 4.68% |
| FRANKLIN RESOURCES INC | 11/27/2024 | 2.77 M | $13.39 M | -3.07% | 3.04% |
| BIOIMPACT CAPITAL LLC | 11/13/2024 | 1.80 M | $8.95 M | 100.00% | 1.97% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.67 M | $8.31 M | 5.74% | 1.83% |
| STATE STREET CORP | 11/14/2024 | 1.50 M | $7.45 M | 52.10% | 1.64% |
| BLUE OWL CAPITAL HOLDINGS LP | 11/14/2024 | 1.23 M | $6.10 M | 7.46% | 1.34% |
| JANNEY MONTGOMERY SCOTT LLC | 10/29/2024 | 923,285 | $4.60 M | 4.86% | 1.01% |
| CITADEL ADVISORS LLC | 11/14/2024 | 871,833 | $4.34 M | 419.53% | 0.96% |
| WOODLINE PARTNERS LP | 11/14/2024 | 816,252 | $4.06 M | 35.82% | 0.90% |
| INVESCO LTD. | 11/12/2024 | 786,579 | $3.92 M | 783.39% | 0.86% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 10/10/2024 | 707,078 | $3.52 M | 0.27% | 0.78% |
| MORGAN STANLEY | 11/14/2024 | 671,489 | $3.34 M | 20.77% | 0.74% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2024 | 589,561 | $2.94 M | 11.24% | 0.65% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 429,800 | $2.14 M | 105.25% | 0.47% |
| BRACEBRIDGE CAPITAL, LLC | 11/14/2024 | 428,571 | $2.13 M | 0.00% | 0.47% |
| 11/12/2024 | 400,125 | $1.99 B | 100.00% | 0.44% | |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 282,431 | $1.41 M | -60.67% | 0.31% |
| LATASH INVESTMENTS, LLC | 11/14/2024 | 243,134 | $1.21 M | 0.00% | 0.27% |
| LEGATO CAPITAL MANAGEMENT LLC | 11/07/2024 | 242,371 | $1.21 M | 0.00% | 0.27% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 236,473 | $1.18 M | -69.88% | 0.26% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 222,687 | $1.11 M | 95.32% | 0.24% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 203,540 | $1.01 M | 4.77% | 0.22% |
| VERITION FUND MANAGEMENT LLC | 11/14/2024 | 199,729 | $994,650 | 100.00% | 0.22% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 192,856 | $960,423 | 0.00% | 0.21% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 185,191 | $922,251 | 100.00% | 0.20% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 177,695 | $884,921 | -22.18% | 0.20% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 160,380 | $798,692 | 24.63% | 0.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2024 | 155,145 | $772,622 | 6.15% | 0.17% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 155,032 | $772,059 | 101.81% | 0.17% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 147,200 | $733,056 | -6.54% | 0.16% |
| CAHILL WEALTH MANAGEMENT, LLC | 11/01/2024 | 142,941 | $711,846 | 20.56% | 0.16% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 137,151 | $683,000 | 525.46% | 0.15% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 133,792 | $666,284 | -2.08% | 0.15% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 130,800 | $651,384 | 100.00% | 0.14% |
| HIGHTOWER ADVISORS, LLC | 11/14/2024 | 108,013 | $537,000 | -0.18% | 0.12% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 11/04/2024 | 107,550 | $535,000 | 100.00% | 0.12% |
| RHUMBLINE ADVISERS | 11/12/2024 | 103,698 | $516,410 | 5.99% | 0.11% |
| BARCLAYS PLC | 11/19/2024 | 99,312 | $495,000 | 285.38% | 0.11% |
| STIFEL FINANCIAL CORP | 11/14/2024 | 95,944 | $477,801 | -75.86% | 0.11% |
| CREATIVE PLANNING | 10/11/2024 | 92,822 | $462,254 | 39.30% | 0.10% |
| UBS GROUP AG | 11/14/2024 | 90,689 | $451,631 | 235.41% | 0.10% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 85,392 | $425,252 | 155.66% | 0.09% |
| CITADEL ADVISORS LLC | 11/14/2024 | 75,100 | $373,998 | 22.31% | 0.08% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 68,670 | $341,977 | -70.16% | 0.08% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 67,887 | $338,077 | 100.00% | 0.07% |
| CITADEL ADVISORS LLC | 11/14/2024 | 60,100 | $299,298 | 10.89% | 0.07% |
| BEACON POINTE ADVISORS, LLC | 11/14/2024 | 60,000 | $298,800 | 0.00% | 0.07% |
Aquestive Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of AQST shares?
During the previous two years, 138 institutional investors and hedge funds held shares of Aquestive Therapeutics, Inc.. The most heavily invested institutionals were:
Bratton Capital Management, L.P.: 9.81 M
BlackRock Funding, Inc. /DE: 5.82 M
VR Adviser, LLC: 5.56 M
VANGUARD GROUP INC: 4.26 M
FRANKLIN RESOURCES INC: 2.77 M
BioImpact Capital LLC: 1.8 M
-
What percentage of Aquestive Therapeutics, Inc. stock is owned by institutional investors?
51.35% of Aquestive Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at AQST ?
Institutional investors have bought a total of 51.86 M shares in the last 24 months. This purchase volume represents approximately $228.20 M in transactions.